Articles you may be interested inThe magnetic phase transition in Mn1.1Fe0.9P1−xGex magnetocaloric alloys J. Appl. Phys. 117, 063909 (2015); 10.1063/1.4906568Magnetic and magnetocaloric properties of La0.85(Na1−xKx)0.15MnO3 ceramics produced by reactive spark plasma sintering Structure evolution and entropy change of temperature and magnetic field induced magneto-structural transition in Mn1.1Fe0.9P0.76Ge0.24
The high-energy ball-milling method was used for fabricating Ni 50 Mn 36.7 In 13.3 fine-sized particles. The as-melt polycrystalline Ni 50 Mn 36.7 In 13.3 alloy exhibits a 14 M modulated martensite structure at room temperature (RT). The atomic pair distribution function analysis together with the differential scanning calorimetry technique proved that the 14 M modulated martensite transformed to a metastable amorphous-like structure after ball milling for 8 hours. Annealing of the ball-milled particles with the amorphous-like phase first led to the crystallization to form a B2 structure at 523 K (250°C), and then an ordered Heusler L2 1 structure (with a small tetragonal distortion) at 684 K (411°C). The annealed particles undergo different structural transitions during cooling, tailored by the atomic arrangements of the high-temperature phase. Low-field thermomagnetization measurements show that the ball-milled particles with the amorphous-like structure or the atomically disordered crystalline structure exhibit a magnetic transition from the paramagnetic-like to the spin-glass state with decreasing temperature, whereas the crystalline particles with the ordered Heusler L2 1 structure present a ferromagnetic behavior with the Curie temperature T c % 310 K (37°C).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.